{"name":"Biogen Idec","permalink":"biogen-idec","crunchbase_url":"http://www.crunchbase.com/financial-organization/biogen-idec","homepage_url":"http://www.biogenidec.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-679-2000","description":"","email_address":"","number_of_employees":null,"founded_year":1978,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jun 16 03:24:48 UTC 2009","updated_at":"Tue Jun 16 12:40:01 UTC 2009","overview":"<p>Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec&#8217;s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idecâ€™s total revenues grew 29 percent over 2007 to $4.1 billion.</p>","image":{"available_sizes":[[[150,55],"assets/images/resized/0004/8826/48826v3-max-150x150.jpg"],[[206,76],"assets/images/resized/0004/8826/48826v3-max-250x250.jpg"],[[206,76],"assets/images/resized/0004/8826/48826v3-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"Corporate Headquarters","address1":"14 Cambridge Center","address2":"","zip_code":"02142","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":42.365622,"longitude":-71.08656}],"relationships":[{"is_past":false,"title":"Chairman","person":{"first_name":"Mr.","last_name":"Bruce R. Ross","permalink":"mr-bruce-r-ross","image":null}},{"is_past":false,"title":"President and Chief Executive Officer","person":{"first_name":"Mr.","last_name":"James C. Mullen","permalink":"mr-james-c-mullen","image":null}},{"is_past":false,"title":"","person":{"first_name":"Mr.","last_name":"Marijn E. Dekkers","permalink":"mr-marijn-e-dekkers","image":null}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/calcimedica-inc-series-c-4m/","source_description":"CalciMedica, Inc.: Series C $4M","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":4,"company":{"name":"CalciMedica","permalink":"calcimedica","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/8731/48731v1-max-150x150.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-250x250.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/intellikine-inc-series-b-51m/","source_description":"Intellikine, Inc.: Series B $51M","raised_amount":51000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":22,"company":{"name":"Intellikine","permalink":"intellikine","image":{"available_sizes":[[[150,29],"assets/images/resized/0005/4526/54526v1-max-150x150.jpg"],[[234,46],"assets/images/resized/0005/4526/54526v1-max-250x250.jpg"],[[234,46],"assets/images/resized/0005/4526/54526v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/virdante-pharmaceuticals-inc-series-a-30m/","source_description":"Virdante Pharmaceuticals, Inc.: Series A $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":25,"company":{"name":"Virdante Pharmaceuticals","permalink":"virdante-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0006/4176/64176v1-max-150x150.jpg"],[[250,71],"assets/images/resized/0006/4176/64176v1-max-250x250.jpg"],[[278,79],"assets/images/resized/0006/4176/64176v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.partners.org/rvl/content/ProvasculonMHT.pdf?mode=PF","source_description":"Provasculon launches with $6M and new home at Biogen incubator","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":24,"company":{"name":"Provasculon","permalink":"provasculon","image":{"available_sizes":[[[150,44],"assets/images/resized/0007/0302/70302v1-max-150x150.jpg"],[[228,68],"assets/images/resized/0007/0302/70302v1-max-250x250.jpg"],[[228,68],"assets/images/resized/0007/0302/70302v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.freshnews.com/news/58246/san-francisco-raven-biotechnologies-inc-raises-483-million-series-d-financing","source_description":"RAVEN BIOTECHNOLOGIES INC. RAISES $48.3 MILLION IN SERIES D FINANCING","raised_amount":48300000,"raised_currency_code":"USD","funded_year":2005,"funded_month":10,"funded_day":12,"company":{"name":"Raven Biotechnologies","permalink":"raven-biotechnologies","image":null}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100908e6990008d&r=Rss&s=DJFVLS","source_description":"IPierian Announces Second Close Of Series B Financing At $28M  ","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":9,"company":{"name":"iPierian","permalink":"ipierian","image":{"available_sizes":[[[142,99],"assets/images/resized/0006/0988/60988v1-max-150x150.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-250x250.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"grant","source_url":"http://www.masshightech.com/stories/2012/09/10/daily28-Museum-of-Science-gets-1M-from-bio-foundation.html","source_description":"Museum of Science gets $1M from bio foundation","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":12,"company":{"name":"Museum of Science","permalink":"museum-of-science","image":{"available_sizes":[[[150,28],"assets/images/resized/0021/1101/211101v1-max-150x150.jpg"],[[238,46],"assets/images/resized/0021/1101/211101v1-max-250x250.jpg"],[[238,46],"assets/images/resized/0021/1101/211101v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[{"description":"Biogen CEO calls it quits after 7 turbulent years ","stoned_year":2010,"stoned_month":1,"stoned_day":5,"source_url":"http://www.fiercebiotech.com/story/biogen-ceo-calls-it-quits-after-7-turbulent-years/2010-01-05?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_text":"","source_description":"Biogen CEO calls it quits after 7 turbulent years ","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}},{"description":"Biogen Idec Inc. is reporting that revenues were $1.2 billion in the third quarter of 2010, up 5 percent from revenue of $801.7 million for the corresponding period last year","stoned_year":2010,"stoned_month":10,"stoned_day":26,"source_url":"http://www.masshightech.com/stories/2010/10/25/daily20-Biogen-revenue-boosted-by-MS-drugs.html","source_text":null,"source_description":"Biogen revenue boosted by MS drugs","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}},{"description":"announced it will cut its work force by 13 percent, closing a site in San Diego and consolidating sites in Eastern Massachusetts into the large sites in Weston and Cambridge","stoned_year":2010,"stoned_month":11,"stoned_day":3,"source_url":"http://www.masshightech.com/stories/2010/11/01/daily25-Biogen-to-cut-work-force-by-13-percent.html","source_text":null,"source_description":"Biogen to cut work force by 13 percent","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}},{"description":"has awarded 12 fellowships to universities and medical centers researching multiple sclerosis, as part of a program the company started in 2006 to further education in the therapeutic area that forms the core of Biogenâ€™s business.","stoned_year":2010,"stoned_month":12,"stoned_day":7,"source_url":"http://www.masshightech.com/stories/2010/12/06/daily24-Biogen-grows-MS-fellowship-program.html","source_text":null,"source_description":"Biogen grows MS fellowship program","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}},{"description":"has bought a subsidiary of Swiss firm Neurimmune Holding AG in a move that will give Biogen potential treatments for neurodegenerative disease like Parkinsonâ€™s disease, at a total potential cost of $427 million","stoned_year":2010,"stoned_month":12,"stoned_day":21,"source_url":"http://www.masshightech.com/stories/2010/12/20/daily14-Biogen-buys-Neurimmune-unit-for-up-to-427M.html","source_text":null,"source_description":"Biogen buys Neurimmune unit for up to $427M","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}},{"description":"Biogen Idec Fully Acquires Biogen DompÃ© Joint Ventures","stoned_year":2011,"stoned_month":9,"stoned_day":6,"source_url":"http://finance.yahoo.com/news/Biogen-Idec-Fully-Acquires-bw-1477000487.html?x=0&.v=1","source_text":"","source_description":"Biogen Idec Fully Acquires Biogen DompÃ© Joint Ventures","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Biogen Idec","permalink":"biogen-idec"}}],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}